The abstract is read at the publisher; the summary is JClub's.
Foundation models are transforming cancer AI, but no single model consistently excels across every task, motivating model-combination strategies for pathology and drug selection.
- Why it matters: Cancer AI needs reliable performance across diverse tasks, yet current foundation models show uneven results, leaving a gap in robustness and generality.
- What they did: Researchers are increasingly combining foundation models to tackle multiple cancer workflows, including interpreting pathology slides and selecting drugs for individual tumors.
- The result: Model combinations are linked to improved performance and robustness across these tasks, supporting broader, more dependable cancer AI systems.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.